SHERMAN JEFFREY W sold 16.2% of their position (42.23K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $334.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/29/2025ACC: 0001867096-25-000145
Director
Since Oct 2021
-42.23K
Net shares
Net seller
$334.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
47.04K acquired · 89.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+47.04K
Price / share
$6.66
Trade value
$313.29K
% of position
21.9%
8/28/2025
214.38K→261.42K
Common Stock
Direct
Shares
−42.23K
Price / share
$7.92
Trade value
$334.52K
% of position
16.2%
8/28/2025
261.42K→219.19K
Total
Net shares
+4.81K
Net value
-$21.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2025 | M · Option Exercise | +47.04K | $6.66 | $313.29K | 21.9% | 214.38K | 261.42K |
| Common Stock Direct | 8/28/2025 | S · Sale | −42.23K | $7.92 | $334.52K | 16.2% | 261.42K | 219.19K |
| Total | +4.81K | -$21.23K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
47.04K shares
Shares
−47.04K
Strike price
6.66
Held after
0.00
Exercisable
—
8/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock47.04K shares | 8/28/2025 | M · Option Exercise | −47.04K | 6.66 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.40K
Total
5.40K indirect5.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.40K | Indirect |
| Total | 5.40K | 5.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported